SI1791872T1 - Biotinilirani heksadekasaharidi, farmacevtski sestavki in njihova uporaba - Google Patents

Biotinilirani heksadekasaharidi, farmacevtski sestavki in njihova uporaba

Info

Publication number
SI1791872T1
SI1791872T1 SI200530615T SI200530615T SI1791872T1 SI 1791872 T1 SI1791872 T1 SI 1791872T1 SI 200530615 T SI200530615 T SI 200530615T SI 200530615 T SI200530615 T SI 200530615T SI 1791872 T1 SI1791872 T1 SI 1791872T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical compositions
biotinylated hexadecasaccharides
hexadecasaccharides
biotinylated
pharmaceutical
Prior art date
Application number
SI200530615T
Other languages
English (en)
Slovenian (sl)
Inventor
Philippe Duchaussoy
Jean Pascal Herault
Jean Marc Herbert
Maurice Petitou
Pierre Savi
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34948342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1791872(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of SI1791872T1 publication Critical patent/SI1791872T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
SI200530615T 2004-09-09 2005-09-07 Biotinilirani heksadekasaharidi, farmacevtski sestavki in njihova uporaba SI1791872T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0409557A FR2874924B1 (fr) 2004-09-09 2004-09-09 Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
EP05805571A EP1791872B1 (fr) 2004-09-09 2005-09-07 Hexadecasaccharides biotinyles, compositions pharmaceutiques et leur utilisation

Publications (1)

Publication Number Publication Date
SI1791872T1 true SI1791872T1 (sl) 2009-06-30

Family

ID=34948342

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530615T SI1791872T1 (sl) 2004-09-09 2005-09-07 Biotinilirani heksadekasaharidi, farmacevtski sestavki in njihova uporaba

Country Status (38)

Country Link
US (3) US20070270342A1 (https=)
EP (1) EP1791872B1 (https=)
JP (1) JP5108519B2 (https=)
KR (1) KR101223364B1 (https=)
CN (1) CN101039963B (https=)
AR (1) AR051286A1 (https=)
AT (1) ATE420118T1 (https=)
AU (1) AU2005284080B2 (https=)
BR (1) BRPI0515078A (https=)
CA (1) CA2577258C (https=)
CY (1) CY1109126T1 (https=)
DE (1) DE602005012287D1 (https=)
DK (1) DK1791872T3 (https=)
EA (1) EA012587B1 (https=)
EC (1) ECSP077272A (https=)
ES (1) ES2320576T3 (https=)
FR (1) FR2874924B1 (https=)
GT (1) GT200500250A (https=)
HN (1) HN2005000518A (https=)
HR (1) HRP20090180T1 (https=)
IL (1) IL181569A (https=)
MA (1) MA28859B1 (https=)
MX (1) MX2007002875A (https=)
MY (1) MY140666A (https=)
NI (1) NI200700063A (https=)
NO (1) NO20071754L (https=)
PA (1) PA8644201A1 (https=)
PE (1) PE20060663A1 (https=)
PL (1) PL1791872T3 (https=)
PT (1) PT1791872E (https=)
RS (1) RS50762B (https=)
SI (1) SI1791872T1 (https=)
SV (1) SV2006002221A (https=)
TN (1) TNSN07053A1 (https=)
TW (1) TW200612970A (https=)
UY (1) UY29102A1 (https=)
WO (1) WO2006030104A1 (https=)
ZA (1) ZA200702255B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912409B1 (fr) * 2007-02-14 2012-08-24 Sanofi Aventis Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
FR2912408A1 (fr) * 2007-02-14 2008-08-15 Sanofi Aventis Sa Heparine comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine,leur procede de preparation,leur utilisation
TW201006479A (en) * 2008-07-18 2010-02-16 Sanofi Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2145624A1 (en) * 2008-07-18 2010-01-20 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2233143A1 (en) * 2009-03-24 2010-09-29 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
FR2935387B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Hexadecasaccharides a activite antithrombotique comprenant une liaison covalente avec une chaine amine
FR2952935B1 (fr) 2009-11-20 2011-12-02 Sanofi Aventis Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563351C (en) 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
EP0300099A1 (en) 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
IL102758A (en) 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NZ264340A (en) 1993-09-01 1995-04-27 Akzo Nobel Nv Bisconjugate comprising two saccharides and a spacer, use in pharmaceutical compositions
FR2751334B1 (fr) 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773801B1 (fr) 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
FR2773804B1 (fr) 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Also Published As

Publication number Publication date
IL181569A0 (en) 2007-07-04
ECSP077272A (es) 2007-03-29
IL181569A (en) 2011-08-31
HRP20090180T1 (en) 2009-05-31
PL1791872T3 (pl) 2009-06-30
CY1109126T1 (el) 2014-07-02
CA2577258A1 (fr) 2006-03-23
ZA200702255B (en) 2008-09-25
US20100279960A1 (en) 2010-11-04
GT200500250A (es) 2006-04-10
US20130004551A1 (en) 2013-01-03
EA012587B1 (ru) 2009-10-30
AR051286A1 (es) 2007-01-03
HN2005000518A (es) 2009-06-01
US20070270342A1 (en) 2007-11-22
RS50762B (sr) 2010-08-31
EP1791872A1 (fr) 2007-06-06
PE20060663A1 (es) 2006-08-21
MY140666A (en) 2010-01-15
JP5108519B2 (ja) 2012-12-26
TNSN07053A1 (fr) 2008-06-02
MA28859B1 (fr) 2007-09-03
MX2007002875A (es) 2007-05-16
AU2005284080A1 (en) 2006-03-23
NI200700063A (es) 2008-03-07
AU2005284080B2 (en) 2011-10-13
TW200612970A (en) 2006-05-01
PA8644201A1 (es) 2006-05-16
CA2577258C (fr) 2013-05-21
ES2320576T3 (es) 2009-05-25
FR2874924B1 (fr) 2006-12-01
HK1113686A1 (en) 2008-10-10
DE602005012287D1 (de) 2009-02-26
FR2874924A1 (fr) 2006-03-10
CN101039963B (zh) 2011-07-27
EA200700594A1 (ru) 2007-08-31
JP2008512538A (ja) 2008-04-24
KR20070051887A (ko) 2007-05-18
BRPI0515078A (pt) 2008-07-01
SV2006002221A (es) 2006-01-13
CN101039963A (zh) 2007-09-19
NO20071754L (no) 2007-04-02
UY29102A1 (es) 2006-04-28
WO2006030104A1 (fr) 2006-03-23
PT1791872E (pt) 2009-03-27
DK1791872T3 (da) 2009-05-04
EP1791872B1 (fr) 2009-01-07
US8557968B2 (en) 2013-10-15
KR101223364B1 (ko) 2013-01-16
ATE420118T1 (de) 2009-01-15
US8703738B2 (en) 2014-04-22

Similar Documents

Publication Publication Date Title
IL223545A0 (en) Pharmaceutical compositions
IL179809A0 (en) Pharmaceutical compositions
GB0408308D0 (en) Pharmaceutical compositions
IL178294A0 (en) Thienopyridine derivatives and pharmaceutical compositions containing the same
IL177480A0 (en) Pharmaceutical composition
IL183986A0 (en) Pharmaceutical compounds and compositions
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
IL181569A0 (en) Biotinylated hexadecasaccharides, preparation and use thereof
PL1837019T3 (pl) Kompozycja farmaceutyczna rozpadająca się w ustach
HU0401177D0 (en) Pharmaceutical composition
IL178067A0 (en) Pharmaceutical dosage forms and compositions
IL186337A0 (en) Stannsoporfin compositions and administration
GB2411355B (en) Pharmaceutical composition
ZA200702038B (en) Pharmaceutical composition drospirenone and ethynyle-stradiol
EP1805154A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0425255D0 (en) Pharmaceutical composition
ZA200701932B (en) Pharmaceutical composition
IL180316A0 (en) Quinolone-containing medicinal composition
ZA200701931B (en) Pharmaceutical composition
GB0407351D0 (en) Pharmaceutical compositions
GB0400971D0 (en) Pharmaceutical compositions
EP1865777A4 (en) STANNSOPORFIN COMPOSITIONS AND ADMINISTRATION
GB0406014D0 (en) Pharmaceutical composition and use
GB0422582D0 (en) Pharmaceutical compositions
GB0411502D0 (en) Pharmaceutical compositions